Skip to main content

and
  1. Article

    Open Access

    Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC

    Lack of biomarkers and in vitro models has contributed to inadequate understanding of the mechanisms underlying the inferior clinical response to immune checkpoint inhibitors (ICIs) in patients with oncogene-d...

    Weijie Ma, Jie Zeng, Shuai Chen, Yue Lyu, Kyra A. Toomey in Biomarker Research (2021)